To include your compound in the COVID-19 Resource Center, submit it here.

ABTL0812: Ph II started

Ability began an open-label, Spanish and French Phase II trial to evaluate

Read the full 121 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE